0001209191-21-064842.txt : 20211116 0001209191-21-064842.hdr.sgml : 20211116 20211116175417 ACCESSION NUMBER: 0001209191-21-064842 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211115 FILED AS OF DATE: 20211116 DATE AS OF CHANGE: 20211116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rutten Guillaume Marie Jean CENTRAL INDEX KEY: 0001596796 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29472 FILM NUMBER: 211417654 MAIL ADDRESS: STREET 1: 1900 S. PRICE ROAD CITY: CHANDLER STATE: AZ ZIP: 85286 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMKOR TECHNOLOGY, INC. CENTRAL INDEX KEY: 0001047127 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 231722724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2045 EAST INNOVATION CIRCLE CITY: TEMPE STATE: AZ ZIP: 85284 BUSINESS PHONE: 480-821-5000 MAIL ADDRESS: STREET 1: 2045 EAST INNOVATION CIRCLE CITY: TEMPE STATE: AZ ZIP: 85284 FORMER COMPANY: FORMER CONFORMED NAME: AMKOR TECHNOLOGY INC DATE OF NAME CHANGE: 19971001 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-15 0 0001047127 AMKOR TECHNOLOGY, INC. AMKR 0001596796 Rutten Guillaume Marie Jean 2045 EAST INNOVATION CIRCLE TEMPE AZ 85284 1 1 0 0 President and CEO Common Stock 2021-11-15 4 M 0 10000 14.17 A 360000 D Common Stock 2021-11-15 4 S 0 25000 23.35 D 335000 D Employee Stock Option (Right-to-Buy) 14.17 2021-11-15 4 M 0 10000 0.00 D 2020-10-30 2030-07-30 Common Stock 10000 252500 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.12 to $23.54.The Reporting Person hereby undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, Amkor Technology, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. This stock option (the "Option") to acquire 375,000 shares of the Issuer's common stock was granted on July 30, 2020 (the "Grant Date") and will vest in equal quarterly installments over three years, such that 100% of the Option will be vested on the third anniversary of the Grant Date. Mark N. Rogers, Attorney-in-Fact for Guillaume Marie Jean Rutten 2021-11-16